STAAR Surgical Company
STAA
$27.97
$0.010.04%
NASDAQ
| 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
|---|---|---|---|---|---|
| Net Income | -673.47% | -564.64% | -194.66% | 6.99% | -35.61% |
| Total Depreciation and Amortization | 58.90% | 52.47% | 34.48% | 8.12% | 5.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.68% | 49.93% | 24.45% | 8.03% | 23.46% |
| Change in Net Operating Assets | 232.45% | 157.35% | 82.86% | 82.52% | 61.00% |
| Cash from Operations | -176.55% | -128.26% | 7.75% | 426.64% | 137.65% |
| Capital Expenditure | 35.83% | 4.05% | -28.62% | -8.53% | -46.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -71.48% | -120.17% | -138.71% | -85.89% | 165.46% |
| Cash from Investing | -88.47% | -149.69% | -179.65% | -431.29% | 138.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 22.36% | -5.03% | -2.48% | -1.23% | 1.23% |
| Issuance of Common Stock | -84.39% | -83.09% | -23.56% | -18.36% | 83.46% |
| Repurchase of Common Stock | -293.90% | -5.55% | 28.23% | 33.35% | 23.94% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -134.06% | -94.39% | -22.81% | -14.47% | 127.62% |
| Foreign Exchange rate Adjustments | 277.92% | 115.03% | -650.00% | 445.30% | -322.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.15% | -137.98% | -140.26% | 2,120.50% | 190.99% |